Searched for
MERCK LIFE SCIENCE
Merck names Dhananjay Singh as MD of Life Science business in IndiaIn his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance a...
Dhananjay Singh takes over as Merck Life Science India MDIn his role as the managing director, Singh will be responsible for driving the life science strategy in India, ensuring governance and com...
Merck India appoints Pratima Reddy as country speakerMerck has appointed Pratima Reddy as its country speaker for India. Reddy, who is currently the GM and managing director of Merck Specialit...
HCL Technologies acquires C3i Solutions for $60 millionC3i Solutions is a wholly owned, independently operated subsidiary of Merck & Co, (known as MSD outside the US and Canada).
German healthcare giant Merck partners with Bengaluru labProcessing special effect pigments, which is used to add glitter in cosmetics, fashion industry, apparels and paints, is still a major chal...
- Merck merges pharma, consumer health units; aims to ramp up businesses
Going against the grain: With the unique hybrid model for India, co aims at building scale & ramping up businesses.
Merck sells GeNei back to founderGerman pharmaceutical and life sciences company Merck has sold Bangalore GeNei, a firm that develops products for biological research, back...
T-Hub to launch its first accelerator for health-tech startupsThe state government backed incubator T-Hub in Hyderabad will launch its first accelerator programme in health-tech in partnership with Mer...
Jubilant Life Sciences gets USFDA nod for migraine treatment drugJubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.
German Pharma firm Merck to shut down Bangalore GeNeiMerck KGaA has decided to close down Bangalore GeNei, a company it had acquired in 2009 to bolster capabilities in design and production of...
Jubilant Life gets USFDA nod for generic anti-asthma tablets"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA ...
Jubilant Life Sciences gets FDA nod for Mycophenolate Mofetil & RizatriptanThe approvals are for Mycophenolate Mofetil in the strengths of 250 mg capsules and 500 mg tablets and Rizatriptan tablets in strengths of ...
Bayer to focus on life science business, spin off polymer divisionThe aim would be to continue the positive development of these activities in the future through further investment in growth, the statement...
Dr Reddy’s , Merck tie up for cheap version of biotech cancer drugsBoth the companies will jointly commercialise the compounds in the US market, and Merck will commercialise the deal in 150 countries, excep...
- Emkay puts buy on Piramal Life Science; target Rs 270
Emkay Global Financial Services has initiated ‘buy’ on Piramal Life Sciences for a target price of Rs 270.
- Ranbaxy enters into pact with Merck for anti-infective drugs
Ranbaxy Laboratories has signed a strategic product development agreement with German pharma major Merck for drug discovery and clinical de...
- Merck Q1 net at Rs 16 cr
Drug firm Merck Ltd today posted a net profit of Rs 15.93 crore for the first quarter ended March 31, 2007, as against Rs 18.54 crore for t...